Literature DB >> 18482006

The role of Snu114p during pre-mRNA splicing.

Lily Novak Frazer1, Verity Nancollis, Raymond T O'Keefe.   

Abstract

Pre-mRNA splicing is an essential step in gene expression where intron regions are removed and coding exon sequences are joined to form an mRNA for translation. Splicing is catalysed by an RNA-protein complex called the spliceosome. A number of spliceosome proteins are required for assembly and remodelling of the spliceosome with pre-mRNA to orient the splice sites correctly and catalyse the two steps of splicing. The spliceosome protein Snu114p is a GTPase that is related to the translation elongation factor EF-2. Snu114p plays a key role in spliceosome remodelling. In the present review, we briefly summarize the current knowledge of the function of Snu114p in pre-mRNA splicing and the role it plays in spliceosome dynamics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482006     DOI: 10.1042/BST0360551

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  17 in total

1.  Advanced Methods for the Analysis of Altered Pre-mRNA Splicing in Yeast and Disease.

Authors:  Huw B Thomas; Raymond T O'Keefe
Journal:  Methods Mol Biol       Date:  2019

2.  EFTUD2 deficiency in vertebrates: Identification of a novel human mutation and generation of a zebrafish model.

Authors:  Brett Deml; Linda M Reis; Sanaa Muheisen; David Bick; Elena V Semina
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-27

3.  Disease modeling of core pre-mRNA splicing factor haploinsufficiency.

Authors:  Katherine A Wood; Charlie F Rowlands; Wasay Mohiuddin Shaikh Qureshi; Huw B Thomas; Weronika A Buczek; Tracy A Briggs; Simon J Hubbard; Kathryn E Hentges; William G Newman; Raymond T O'Keefe
Journal:  Hum Mol Genet       Date:  2019-11-15       Impact factor: 6.150

4.  Identification of novel susceptibility genes for non-syndromic cleft lip with or without cleft palate using NGS-based multigene panel testing.

Authors:  Justyna Dąbrowska; Barbara Biedziak; Anna Szponar-Żurowska; Margareta Budner; Paweł P Jagodziński; Rafał Płoski; Adrianna Mostowska
Journal:  Mol Genet Genomics       Date:  2022-07-01       Impact factor: 2.980

5.  Analysis of synthetic lethality reveals genetic interactions between the GTPase Snu114p and snRNAs in the catalytic core of the Saccharomyces cerevisiae spliceosome.

Authors:  Lily Novak Frazer; Simon C Lovell; Raymond T O'Keefe
Journal:  Genetics       Date:  2009-07-20       Impact factor: 4.562

Review 6.  The function of the NineTeen Complex (NTC) in regulating spliceosome conformations and fidelity during pre-mRNA splicing.

Authors:  Rebecca Hogg; Joanne C McGrail; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

7.  Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53.

Authors:  Marie-Claude Beauchamp; Anissa Djedid; Eric Bareke; Fjodor Merkuri; Rachel Aber; Annie S Tam; Matthew A Lines; Kym M Boycott; Peter C Stirling; Jennifer L Fish; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

8.  Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells.

Authors:  Naoki Sato; Masao Maeda; Mai Sugiyama; Satoko Ito; Toshinori Hyodo; Akio Masuda; Nobuyuki Tsunoda; Toshio Kokuryo; Michinari Hamaguchi; Masato Nagino; Takeshi Senga
Journal:  Cancer Med       Date:  2014-12-01       Impact factor: 4.452

9.  The NineTeen Complex (NTC) and NTC-associated proteins as targets for spliceosomal ATPase action during pre-mRNA splicing.

Authors:  Rogerio Alves de Almeida; Raymond T O'Keefe
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

10.  Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma.

Authors:  C Lv; X J Li; L X Hao; S Zhang; Z Song; X D Ji; B Gong
Journal:  Clin Transl Oncol       Date:  2021-07-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.